Skip to main content

Table 1 Baseline characteristics of the study population enrolled at the health facilities and the district hospital

From: Accuracy of a Plasmodium falciparum specific histidine-rich protein 2 rapid diagnostic test in the context of the presence of non-malaria fevers, prior anti-malarial use and seasonal malaria transmission

 

Included N = 683

Malaria microscopy positive n = 340

Malaria microscopy negative n = 343

PfHRP2 positive n = 475

PfHRP2 negative n = 208

Sex (%)

 Male

369 (54.0)

176 (51.8)

193 (56.3)

256 (53.9)

113 (54.3)

 Female

314 (46.0)

164 (48.2)

150 (43.7)

219 (46.1)

95 (45.7)

Age (%), months

 ≤12

200 (29.3)

64 (18.8)

136 (39.7)

110 (23.2)

90 (43.3)

 >12

483 (70.7)

276 (81.2)

207 (60.3)

365 (76.8)

118 (56.7)

Temperature (%), °C

 ≥37.5–≤38.5

340 (49.8)

153 (45.0)

187 (54.5)

221 (46.5)

119 (57.2)

 >38.5–≤39.5

241 (35.3)

123 (36.2)

118 (34.4)

177 (37.3)

64 (30.8)

 >39.5

102 (14.9)

64 (18.8)

38 (11.1)

77 (16.2)

25 (12.0)

All causes (%)

73 (10.7)

11 (3.2)

62 (18.1)

47 (9.9)

26 (12.5)

BSI (%)

41 (6.0)

6 (1.8)

35 (10.2)

29 (6.1)

12 (5.8)

UTI (%)

10 (1.5)

3 (0.9)

7 (2.0)

9 (1.9)

1 (0.5)

Rotavirus/adenovirus (%)

25 (3.7)

3 (0.9)

22 (6.4)

12 (2.5)

12 (5.8)

  1. BSI: bloodstream infection; UTI: urinary tract infection; PfHRP2: Plasmodium falciparum histidine-rich protein-2